results of recent clinical trials on secondary prevention of ischemic heart disease indicate that judicious , long-term administration of adrenergic beta blockers and platelet-active drugs such as aspirin and persantine ( dipyridamole ) would seem to yield protection against mortality associated with acute myocardial infarction , including sudden death .
C0700020
persantine
C0012582
dipyridamole